Fig. 14 | Scientific Reports

Fig. 14

From: In silico approaches unveil the mechanism of action of Eclipta prostrata against acute myeloid leukemia

Fig. 14

Survival analysis among patients with AML using Kaplan–Meier Plots to identify potential prognostic biomarkers. The blue line indicates a low-level protein group, and the red line indicates high-level protein groups. The larger gaps between those two groups indicate significant survival differences among patients. (A-E) shows significant differences between survival with logrank p-value < 0.05, and (F) AKT1 is used as a negative control, which doesn’t show any survival difference.

Back to article page